USA - NASDAQ:DYNT - US2681575005 - Common Stock
The current stock price of DYNT is 0.244 USD. In the past month the price decreased by -39.15%. In the past year, price decreased by -68.32%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 69.98 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Dynatronics Corp. engages in the design, manufacture, and market of restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company is headquartered in Salt Lake City, Utah and currently employs 154 full-time employees. The firm designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The firm's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.
DYNATRONICS CORP
Bldg D, 7030 Park Centre Drive
Salt Lake City UTAH 55121 US
CEO: John A. Krier
Employees: 154
Phone: 18015687000
Dynatronics Corp. engages in the design, manufacture, and market of restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company is headquartered in Salt Lake City, Utah and currently employs 154 full-time employees. The firm designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The firm's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.
The current stock price of DYNT is 0.244 USD. The price increased by 15.09% in the last trading session.
DYNT does not pay a dividend.
DYNT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
7 analysts have analysed DYNT and the average price target is 4.08 USD. This implies a price increase of 1572.13% is expected in the next year compared to the current price of 0.244.
DYNATRONICS CORP (DYNT) currently has 154 employees.
DYNATRONICS CORP (DYNT) will report earnings on 2024-09-26, after the market close.
ChartMill assigns a fundamental rating of 1 / 10 to DYNT. Both the profitability and financial health of DYNT have multiple concerns.
Over the last trailing twelve months DYNT reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS increased by 10.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.49% | ||
| ROE | -34.58% | ||
| Debt/Equity | 0.26 |
7 analysts have analysed DYNT and the average price target is 4.08 USD. This implies a price increase of 1572.13% is expected in the next year compared to the current price of 0.244.
For the next year, analysts expect an EPS growth of 35.73% and a revenue growth -14.58% for DYNT